Source: Annual Congress 2012 - How to use technology to provide better critical care



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kardara, N. Maniatis, A. Sfika, A. Kotanidou, C. Roussos, A. Armaganidis, S. Hatziantoniou, S. Orthanos (Athens, Greece). Biological effects of nanostructured lipid carriers. Eur Respir J 2012; 40: Suppl. 56, 396

Member's Comments

No comment yet.

Related content which might interest you: Effect of avidin protein coated and uncoated mesoporous silica drug nanocarriers on their bioresponse in the lung Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Genetic influence on inflammatory response in rats exposed to nanosized titanium dioxide particles Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 Adhesive properties of human endothelial cells exposed to amorphous silica nanoparticles Source: Annual Congress 2010 - Causal factors and mechanisms of outdoor air pollution and nanoparticulates Year: 2010 Effect of nanoparticles on the respiratory epithelium in vitro: role of chemical composition and particle size Source: Eur Respir J 2007; 30: Suppl. 51, 476s Year: 2007 Polyacrylate nanoparticles: toxicity or new nanomedicine? Source: Eur Respir J 2010; 36: 218-221 Year: 2010 Nebulised lipid–polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells Source: ERJ Open Res, 5 (2) 00161-2018; 10.1183/23120541.00161-2018 Year: 2019 Medical nanoparticles for next generation drug delivery to the lungs Source: Eur Respir J 2014; 44: 765-774 Year: 2014 Elevated markers of lipid oxidative damage among workers exposed to engineered TiO2 nanoparticles Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes Year: 2016 Mesoporous silica-based nanoparticles for targeted delivery of proteasome inhibitors to the lung Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 Deposition of ultrafine (nano)particles in the human lung and the mechanisms behing the health effects Source: International Congress 2014 – Nanomaterials and respiratory health Year: 2014 Bioresorbable polymer structures - promising carriers for prolonged forms of anti-tuberculosis drugs Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Inhaled solid lipid nanoparticles as a new tool for drug delivery in the lung Source: Annual Congress 2009 - New drugs for airways disease Year: 2009 Immune responses to coated super-paramagnetic iron oxide nanoparticles Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Probing the carcinogenic potential of carbon nanotubes Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Imaging of the interaction of fine particles and nanoparticles with lung cells Source: Annual Congress 2009 - WS1 - New imaging methods for the researcher: believe what you see! Year: 2009 Designed core-shell nanoparticles: intracellular localization and pro-inflammatory cytokine release in lung cells Source: Annual Congress 2009 - Lung cell biology and immunology Year: 2009 Autophagic and apoptotic changes in macrophages in response to graphene oxides with or without chemical modification Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Nanostructured lipid carriers prevent acute lung injury by acid aspiration Source: Annual Congress 2010 - Acute respiratory failure Year: 2010 The effect of ferric oxide nanoparticles on pulmonary morphology, redox system and some immune components Source: Annual Congress 2007 - Advances in respiratory mechanics Year: 2007